Market Performance - The stock price of Jiuan Medical reached a peak of 44.90 yuan and closed at 44.67 yuan, with a daily increase of 8.34%, surpassing the 60-day moving average of 41.43 yuan [1] - The net inflow of main funds was approximately 99.34 million yuan, with significant buying from large orders, indicating active market trading with a turnover rate of 5.03% [1] - Despite a net repayment of financing on February 13, the current financing balance of 1.11 billion yuan is at a relatively low level compared to the past year, potentially allowing for further capital inflow [1] Company Fundamentals - The company's net profit attributable to shareholders increased by 16.11% year-on-year to 1.589 billion yuan, primarily driven by contributions from asset management business [2] - The C-end reagent kit business showed quarter-on-quarter growth in Q3 2025, with ongoing progress in new product development such as CGM and quadruple detection [2] - Morgan Healthcare Fund increased its holdings in Jiuan Medical to 624,200 shares in Q4, representing 5.46% of the fund's net value [2] Technical Indicators - The stock price broke through the upper Bollinger Band at 43.99 yuan, with the MACD indicator showing enhanced bullish momentum [3] - The KDJ indicator's J line rose to 84.3, indicating a strong short-term technical outlook [3] - The medical device sector rose by 0.69% on the same day, along with active performance from Tianjin regional concept stocks, which increased by 1.55%, contributing to the stock's upward movement [3]